From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
The DARPin platform has the AMD and DME treatment burden firmly in its sights – but that’s only the beginning
How important is a joint-up approach to caring for patients with diabetes and diabetic eye disease?
Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future
AI image interpretation will not solve the diabetic retinopathy epidemic
Diabetes prevalence is set to grow by 48 percent over the next 25 years – so where does that leave ophthalmologists?
What does the future hold for the management – and treatment – of diabetic eye disease?
The winners of the ICO-Allergan Advanced Research Fellowship… in conversation.
Could an FDA-approved asthma medication offer a therapeutic pathway for diabetic retinopathy?
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.